A detailed history of Geode Capital Management, LLC transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 271,026 shares of IKNA stock, worth $439,062. This represents 0.0% of its overall portfolio holdings.

Number of Shares
271,026
Previous 256,707 5.58%
Holding current value
$439,062
Previous $423,000 10.64%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.6 - $1.85 $22,910 - $26,490
14,319 Added 5.58%
271,026 $468,000
Q2 2024

Aug 09, 2024

SELL
$1.24 - $1.82 $422,306 - $619,837
-340,570 Reduced 57.02%
256,707 $423,000
Q1 2024

May 13, 2024

BUY
$1.27 - $2.0 $86,243 - $135,816
67,908 Added 12.83%
597,277 $848,000
Q4 2023

Feb 13, 2024

BUY
$1.33 - $4.4 $16,163 - $53,473
12,153 Added 2.35%
529,369 $1.04 Million
Q3 2023

Nov 13, 2023

BUY
$4.09 - $6.43 $204,569 - $321,609
50,017 Added 10.71%
517,216 $2.24 Million
Q2 2023

Aug 11, 2023

BUY
$3.5 - $7.31 $785,676 - $1.64 Million
224,479 Added 92.48%
467,199 $3.06 Million
Q1 2023

May 15, 2023

BUY
$2.62 - $4.97 $16,469 - $31,241
6,286 Added 2.66%
242,720 $837,000
Q4 2022

Feb 13, 2023

SELL
$2.0 - $3.7 $1,028 - $1,901
-514 Reduced 0.22%
236,434 $628,000
Q3 2022

Nov 14, 2022

BUY
$3.46 - $6.0 $464,588 - $805,644
134,274 Added 130.78%
236,948 $841,000
Q2 2022

Aug 12, 2022

SELL
$3.23 - $7.4 $731,042 - $1.67 Million
-226,329 Reduced 68.79%
102,674 $454,000
Q1 2022

May 13, 2022

BUY
$5.61 - $13.85 $249,919 - $617,003
44,549 Added 15.66%
329,003 $2.01 Million
Q4 2021

Feb 11, 2022

BUY
$10.52 - $16.96 $946,726 - $1.53 Million
89,993 Added 46.28%
284,454 $3.57 Million
Q3 2021

Nov 12, 2021

BUY
$9.82 - $15.23 $758,212 - $1.18 Million
77,211 Added 65.85%
194,461 $2.45 Million
Q2 2021

Aug 13, 2021

BUY
$13.27 - $26.0 $1.56 Million - $3.05 Million
117,250 New
117,250 $1.65 Million

Others Institutions Holding IKNA

About Ikena Oncology, Inc.


  • Ticker IKNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,257,500
  • Market Cap $58.7M
  • Description
  • Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...
More about IKNA
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.